Medical Xpress news
Medical Xpress / Experimental drug protects mitochondria and prevents kidney injury in mice
Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ranging from sepsis to ...
Medical Xpress / Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give ...
Medical Xpress / Common gout drug may reduce risk of heart attack and stroke
A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new review.
Medical Xpress / Halting pancreatic cancer spread: Protein-degrading drugs show promise in preclinical models
Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors, including pancreatic ...
Medical Xpress / Researcher proposes new medical training on cannabis use
Maryland is one of 38 US states, along with three territories and the District of Columbia, that have legalized cannabis for medical purposes. This legal sea change has generated increasing interest in and use of cannabis ...
Medical Xpress / Discovery of key to joint regeneration could help regrow lost limbs
Researchers at Texas A&M University have uncovered a key element of joint cartilage regrowth, which brings them one step closer to regrowing human limbs.
Medical Xpress / In a good mood? Maybe it's time for your next masterpiece
Your happiness and self-fulfillment might have a direct impact on how creative you are, according to new research from the University of Georgia.
Medical Xpress / Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see ...
Medical Xpress / Researchers redefine hip arthroscopy with breakthrough surgical device
There's a new tool in the hands of surgeons making waves in the world of hip arthroscopy.
Medical Xpress / The internal clock of immune cells: Is the immune system younger in the morning?
As the immune system ages, it reacts more slowly to pathogens, vaccines become less effective, and the risk of cancer increases. At the same time, the immune system follows a 24-hour rhythm, as the number and activity of ...
Medical Xpress / Understudied eating disorder matches anorexia, bulimia severity
A diagnosis often viewed as less serious than anorexia and bulimia—and the most common eating disorder worldwide—can cause just as much harm, a new study has found.
Medical Xpress / Extending anti-clotting treatment linked to lower rates of new clots
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published ...
